TP53 and cancer: The top six pathways with significant differences were the longevity-regulating pathway (mammals), the forkhead box O (FoxO) signaling pathway, the riboflavin metabolism pathway, the p53 signaling pathway, the pathway of transcriptional misregulation in cancers, and the glycerophospholipid metabolism pathway (Fig. 2A).